drugset / Trial / NCT00779545
A Study of Mometasone Furoate Nasal Spray in Perennial Allergic Rhinitis (Study P03748)(COMPLETED)
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a multicenter, randomized, double-blind within the dose level, parallel group comparison of mometasone furoate nasal spray in subjects with perennial allergic rhinitis to examine the minimal effective dose, the recommended dose, and the dosing regimen.
Timeline
- Start
- 2004-04-08
- Primary completion
- 2004-08-06
- Completion
- 2004-08-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mometasone furoate | Other / unclassified | 100 ug | Intranasal |
| Subject | Mometasone furoate | Other / unclassified | 200 ug | Intranasal |
| Subject | Mometasone furoate | Other / unclassified | 400 ug | Intranasal |